Jan. 11 - The Medical College of Wisconsin, which runs its own Human and Molecular Genetics Center in Wauwatosa, is the sponsor of an upcoming Discovery World exhibit that will allow visitors to explore the secrets of the human genome. The 4,400-square-foot exhibit was created by the Smithsonian National Museum of Natural History and the National Human Genome Research Institute. Milwaukee Business Journal
Dec. 16 - Nita H. Salzman, MD, PhD, professor of pediatrics and microbiology and molecular genetics, and an associate director for the Medical Scientist Training Program (MSTP) at the Medical College of Wisconsin (MCW); and Christopher J. Kristich, PhD, associate professor of microbiology and molecular genetics at MCW investigated therapies to prevent antibiotic resistant infections originating in the gastrointestinal tract. The research focused on Enterococcus faecalis (E. faecalis), a gastrointestinal tract bacterium with the ability to cause a variety of hospital-acquired infections (HAI). The findings of the study were published in Nature.
Medical College of Wisconsin researchers are studying intestinal bacteria as a promising new approach for the prevention of heart attacks and a range of other conditions, including pediatric liver disease and antibiotic-resistant, hospital-acquired infections.
Oct. 15 - Medical College of Wisconsin (MCW) biotech spin-off company, Protein Foundry LLC, has received an 18 month, $250,000 Small Business Innovation Research Contract (SBIR) from the National Institutes of Health National Heart, Lung and Blood Institute. This contract supports a collaborative project with Joseph T. Barbieri, PhD, professor and interim chair of microbiology and molecular genetics at MCW, to develop a safe and efficient method to deliver therapeutic proteins into nerve cells.
Sept. 9 - The Milwaukee Journal Sentinel reports that in a study published in Cancer Research, MCW scientists demonstrated that a chemokine protein (CXCL12), an important molecule of the body's immune system, can suppress metastasis which is the spread of cancer from one part of the body to another. Milwaukee Journal Sentinel and Wisconsin Technology Council
Sept. 1 - Scientists at the Medical College of Wisconsin (MCW) have demonstrated that a chemokine protein (CXCL12), an important molecule of the body's immune system, can suppress metastasis which is the spread of cancer from one part of the body to another.
Aug. 10 - The Medical College of Wisconsin (MCW) has received a four-year $1.5 million grant from the National Institutes of Health’s (NIH) National Heart, Lung and Blood Institute to research the pathophysiology of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients (HSCT).
July 27 - Joseph Barbieri, PhD, (Microbiology & Molecular Genetics) received a five-year, $1.5 million training grant from the National Institute of General Medical to fund MCW’s Medical Scientist Training Program. The training grant supports students seeking a dual MD-PhD degree by providing a stipend and full tuition scholarship during all years of graduate and medical studies. Spanish Journal
June 9 - Mitchell Grayson, MD, professor of asthma, allergy and immunology, was interviewed for an article in the Wall Street Journal. The article explored allergies and air pollution, and how traveling overseas might exacerbate existing allergies. Wall Street Journal
June 9 - The Wisconsin Breast Cancer Showhouse awarded two-year, $100,000 grants to three MCW faculty members: Michael Flister, PhD, (Physiology), Hyeongnam (Joseph) Jeong, PhD, (Dermatology), and Mark McNally, PhD, (Microbiology & Molecular Genetics). Wauwatosa Now
External Communications Consultant
(414) 955-4744 (Office)
Richard N. Katschke
Associate Vice President
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53226
Directions & Maps